USANA Health Sciences Inc - USNA STOCK NEWS

USANA Health Sciences has been named Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association in the mega-sized companies category. The company manufactures approximately 70% of its products in its FDA-registered facility, excluding Mainland China. USANA's manufacturing capabilities include high-speed tablet presses that can produce 60,000 to 500,000 tablets per hour while maintaining quality control. The facility is GMP certified by USP and NSF, with multiple products certified by ConsumerLab.com. The company's in-house manufacturing while maintaining high GMP standards has made it the most trusted health and wellness company among Olympic and professional athletes.

USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting National Gratitude Month this November, highlighting gratitude's significant impact on health and wellness. Recent studies, including a July 2024 Harvard research, demonstrate that grateful individuals experience better sleep, reduced stress, healthier diets, and increased physical activity.

Guest shares three practical ways to enhance gratitude: maintaining a Gratitude Jar, writing thank-you notes, and performing random acts of kindness. As author of 'All the Right Reasons', Guest emphasizes core values of faith, family, service, gratitude, and honesty. The book's proceeds support feeding hungry children, with each purchase providing 40 meals.

USANA Health Sciences reported its Q3 2024 financial results, showing a 6% decline in net sales to $200 million compared to Q3 2023. Diluted EPS decreased by 5% to $0.56. The company updated its fiscal year 2024 outlook, projecting net sales of approximately $850 million and diluted EPS of $2.45.

Key highlights include:

• Active customers decreased by 3% to 452,000
• Asia Pacific region accounted for 80% of consolidated net sales
• Americas and Europe region represented 20% of consolidated net sales
• $30 million generated in operating cash flow
• $365 million in cash and cash equivalents, remaining debt-free

The company cited continued top-line headwinds across key markets, with challenges in attracting new customers due to cautious consumer sentiment, particularly in mainland China.

USANA Health Sciences, Inc. announces that 11 of its products have been listed in the prestigious Prescribers' Digital Reference® (PDR). This inclusion adds credibility to USANA's product quality and provides supplemental facts directly to prescribers. The listed products include BiOmega, CoQuinone 30, Core Minerals, HealthPak, Hepasil DTX, MagneCal D, USANA Probiotic, Procosa, Proflavanol C100, Visionex, and Vita Antioxidant.

Brent Neidig, USANA's chief commercial officer, expressed excitement about the listing, noting its positive impact on distributors' business growth and customer engagement. The PDR, formerly known as the Physicians' Desk Reference®, is a important resource for drug-prescribing information, offering providers digital access to trusted data.

Dr. Rob Sinnott, USANA's chief science officer, highlighted the benefit of getting product information to prescribers, especially for customers who are prescribers themselves, calling it a win for USANA.

USANA Health Sciences (NYSE:USNA) has announced that its third quarter 2024 results will be released after the market closes on Tuesday, October 22, 2024. Following the earnings release, the company will post a Management Commentary document on its Investor Relations website. USANA will hold a conference call to discuss the results with analysts and institutional investors on Wednesday, October 23, 2024, at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed through the company's Investor Relations website. USANA develops and manufactures high-quality nutritional supplements, healthy foods, and personal care products sold directly to Associates and Preferred Customers across multiple countries worldwide.

USANA Health Sciences Executive Chairman Kevin Guest emphasizes the connection between country music and mental wellness during Country Music Month this October. Guest, also a musician and author, highlights five key benefits of incorporating music into daily life for mental balance:

• Emotional Release
• Stress Reduction
• Connection and Community
• Mindful Presence
• Inspiration and Motivation

Guest's book, 'All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony', explores the transformative power of music. USANA (NYSE: USNA) promotes a balanced life where music and health harmonize. The company, founded in 1992, operates in 25 countries, focusing on health, wellness, and entrepreneurial success.

USANA Health Sciences, Inc. celebrates the outstanding performance of its sponsored athletes at the 2024 Summer Olympic and Paralympic Games in Paris. The 265 USANA-sponsored athletes secured an impressive total of 99 medals, including 40 Gold, 33 Silver, and 26 Bronze.

Notable achievements include USA Swimming's 28 medals and China National Sports Training Center's success across multiple disciplines. Individual USANA athlete medalists like Alex Portal (Para Swimming, France) and Jessica Long (Para Swimming, USA) also contributed significantly to the medal count.

USANA's Chief Commercial Officer, Brent Neidig, expressed pride in the athletes' performance and looks forward to their participation in future Olympic and Paralympic events.

USANA Health Sciences Executive Chairman Kevin Guest emphasizes the critical role of entrepreneurs in driving innovation and economic growth. In his bestseller, 'All the Right Reasons,' Guest shares qualities for entrepreneurial success, including:

• Innovative thinking to develop unique solutions
• Resilience to overcome setbacks
• Strong communication skills to build relationships and inspire others

Guest's book proceeds go towards feeding hungry children, with each purchase providing 40 meals. USANA (NYSE: USNA), a global health and wellness leader, recognizes the importance of social wellness in business success. The company operates in 25 countries, focusing on clear communication to build trust with customers and distributors.

USANA Health Sciences, Inc. (NYSE: USNA) has introduced two new products: Celavive Resurfacing Serum and Whey Protein Isolate. The Resurfacing Serum combines alpha and beta hydroxy acids, niacinamide, peptides, and bakuchiol to improve skin texture, clarity, brightness, and firmness. The Whey Protein Isolate offers 25 grams of premium, grass-fed whey protein per serving, supporting muscle mass development and overall health. It is keto and paleo friendly, with zero sugars, one carb, and no artificial additives.

Brent Neidig, USANA's chief commercial officer, expressed excitement about the launch, highlighting the high-end nature of the serum and the company's response to customer demand for a clean, effective protein powder. Dr. Rob Sinnott, USANA's chief science officer, praised the R&D and product teams for their innovative work on these products.